Category: Diabetes

Dapavel-M 10/500 Tablet ER is an extended-release oral anti-diabetic combination medicine used to manage Type 2 Diabetes Mellitus in adults. It combines Dapagliflozin (10mg) and Metformin (500mg) to provide a dual mechanism of blood glucose control.

• Dapagliflozin is an SGLT2 inhibitor that blocks glucose reabsorption in the kidneys, promoting glucose excretion via urine, helping to lower blood sugar levels.

• Metformin, a biguanide, reduces hepatic glucose production and enhances insulin sensitivity in the body.

The extended-release formulation allows for once-daily dosing, maintaining more consistent blood sugar control over 24 hours. This combination is effective in controlling both fasting and postprandial glucose levels, supporting weight management, and reducing cardiovascular risks associated with diabetes.

Uses:

• Treatment and management of Type 2 Diabetes Mellitus

• Helps achieve and maintain optimal glycemic control

• Reduces risk of heart failure and cardiovascular complications

• Supports weight reduction and better metabolic control

• Improves insulin sensitivity and glucose utilization

Dosage:

• Take the tablet once daily as prescribed by your doctor, preferably with a meal to minimize gastrointestinal side effects.

• Swallow the tablet whole with water; do not crush, chew, or break it.

• If a dose is missed, take it as soon as possible unless it is nearly time for your next dose. Do not double doses.

• Dose adjustments may be needed based on blood sugar levels and treatment response.

How to Use:

Take Dapavel-M 10/500 Tablet ER at the same time each day for consistent blood glucose control. Combine with a balanced diet, regular exercise, and routine blood sugar monitoring. Continue therapy even if blood sugar appears normal unless advised by your doctor.

Precautions:

• Not intended for Type 1 Diabetes or diabetic ketoacidosis.

• Avoid alcohol, as it increases risk of hypoglycemia and lactic acidosis.

• Use cautiously in patients with kidney, liver, or heart issues.

• Maintain adequate hydration to prevent dehydration and urinary tract infections.

• Regularly monitor renal function and blood glucose levels.

• Consult your doctor before use during pregnancy or breastfeeding.

• Be cautious when combined with diuretics or blood pressure medicines.

Side Effects:

Common:

• Frequent urination

• Urinary tract infection (UTI)

• Nausea, vomiting, or stomach discomfort

• Increased thirst

• Low blood sugar (when combined with other anti-diabetic drugs)

Less Common:

• Fatigue or dizziness

• Back pain

• Constipation or mild loss of appetite

Serious (seek immediate medical attention):

• Signs of lactic acidosis (muscle pain, tiredness, rapid breathing)

• Ketoacidosis (abdominal pain, vomiting, confusion)

• Severe urinary or genital infections

• Allergic reactions (rash, swelling, difficulty breathing)

Dapavel-M 5/500 Tablet is an oral anti-diabetic combination medicine used to manage Type 2 Diabetes Mellitus in adults. It contains Dapagliflozin and Metformin, two complementary drugs that work together to provide better control over blood glucose levels.

• Dapagliflozin (5mg) belongs to the class of SGLT2 inhibitors and works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be eliminated through urine.

• Metformin (500mg) is a biguanide that reduces glucose production in the liver and increases the body’s sensitivity to insulin.

This dual-action therapy helps regulate fasting and post-meal blood sugar levels, improve insulin efficiency, and support weight control. Dapavel-M also contributes to reducing the risk of heart failure and other diabetes-related complications when used as part of a complete diabetes management plan involving diet and exercise.

Uses:

• Management of Type 2 Diabetes Mellitus

• Helps in maintaining optimal blood sugar levels

• Reduces the risk of cardiovascular complications in diabetic patients

• Aids in weight reduction and blood pressure control

• Improves insulin sensitivity and glucose metabolism

Dosage:

• The dosage should be taken exactly as prescribed by your doctor.

• Usually taken once or twice daily with meals to minimize stomach upset.

• Swallow the tablet whole with water; do not crush or chew.

• If a dose is missed, take it as soon as possible unless it’s time for the next one—do not double the dose.

• Your doctor may adjust the dose depending on your blood sugar control and medical response.

How to Use:

Take Dapavel-M 5/500 Tablet with food to reduce gastrointestinal side effects caused by Metformin. Follow a diabetic-friendly diet, engage in regular physical activity, and monitor blood glucose levels regularly for effective control. Continue taking the medication even if you feel better, as diabetes requires consistent long-term management.

Precautions:

• Avoid alcohol, as it increases the risk of low blood sugar and lactic acidosis (a rare but serious side effect of Metformin).

• Not recommended for Type 1 Diabetes or diabetic ketoacidosis.

• Inform your doctor if you have kidney, liver, or heart problems.

• Maintain proper hydration to avoid dehydration and urinary infections.

• Regularly monitor kidney function and blood sugar levels.

• Consult your doctor before using during pregnancy or breastfeeding.

• Caution is advised when used with diuretics or blood pressure-lowering drugs, as they may increase dehydration risk.

Side Effects:

Common:

• Frequent urination

• Urinary tract infection (UTI)

• Nausea, vomiting, or stomach upset

• Increased thirst

• Mild hypoglycemia (low blood sugar) when combined with other anti-diabetic medicines

Less Common:

• Fatigue or dizziness

• Back pain

• Constipation or loss of appetite

Serious (seek medical attention):

• Signs of lactic acidosis (muscle pain, tiredness, difficulty breathing)

• Ketoacidosis (vomiting, abdominal pain, confusion)

• Severe urinary or genital infections

• Allergic reactions (rash, itching, swelling)

DAPZIGARD 5 M Tablet is a dual oral antidiabetic designed for adults with type 2 diabetes mellitus, especially when blood sugar is not controlled by metformin or other single agents alone.

Uses / Indications

• Type 2 diabetes mellitus: Improves glycemic control in adults; can be used as monotherapy or, more commonly, as part of combination therapy with other antidiabetic agents.

• Additional benefits: May reduce risk of heart failure hospitalization and protect kidney function in eligible patients.

How it Works / Key Benefits

• Dapagliflozin: Blocks SGLT2 in the kidney, increasing urinary glucose excretion, thereby lowering blood sugar, with the added benefit of modest blood pressure reduction, weight loss, and cardioprotection.

• Metformin (ER): Inhibits liver glucose production, improves insulin sensitivity, and reduces glucose absorption in the gut, with the sustained-release formulation providing better GI tolerability.

• Dual action targets both fasting and postprandial glucose, with a reduced risk of hypoglycemia when used alone.

Dosage & Administration

• Dose is as prescribed by the physician, typically one tablet once daily with food for best tolerability.

• Swallow whole with water; do not break, crush, or chew.

• Do not use in severe kidney/liver impairment; baseline and regular kidney function tests are recommended.

• Should not be used in pregnancy, those under 18 years, or when dehydrated.

Safety & Side Effects

• Common: Genital yeast infections, urinary tract infection, mild dehydration, increased urination, diarrhea, nausea, stomach upset.

• Occasional/serious: Lactic acidosis (with metformin; rare but serious), severe water/electrolyte loss, low blood sugar (more likely with sulfonylureas/insulin), rare ketoacidosis.

• Avoid alcohol—raises risk of lactic acidosis with metformin.

• Report symptoms like severe weakness, muscle pain, breathing difficulty, or reduced urination to your doctor.

Note:
DAPZIGARD 5 M is best used as part of a holistic diabetes management plan including diet, exercise, and regular medical follow-up for optimal blood sugar and complication risk reduction.

DAPZIGARD 5 M FORTE Tablet is a dual oral antidiabetic for adults with type 2 diabetes, particularly when single therapy or lower-dose combinations fail to achieve adequate glycemic control.

Uses / Indications

• Type 2 diabetes mellitus: Used to improve blood sugar control in adults, usually alongside proper diet and exercise, or in combination with other antidiabetic agents (like insulin or GLP-1 agonists).

• Especially beneficial for overweight patients or those with high cardiovascular/kidney risk.

How it Works / Key Benefits

• Dapagliflozin: Increases urinary glucose excretion by inhibiting SGLT2 in kidney tubules, lowering blood sugar, with added benefits of modest weight loss and mild blood pressure reduction.

• Metformin (ER): Reduces liver glucose production and increases insulin sensitivity, with sustained release to minimize GI side effects and keep sugar controlled throughout the day.

• Combination provides broader control of fasting and post-meal blood sugar, and offers kidney and heart protection in select patients.

Dosage & Administration

• Taken once daily (dose as per prescription), ideally with the main meal; swallow whole with water—do not break, crush, or chew.

• Not recommended for moderate to severe kidney or liver disease, pregnancy, breastfeeding, or in children/adolescents under 18 years.

• Avoid alcohol—raises lactic acidosis risk with metformin.

• Regular kidney function, blood sugar, and periodic blood tests are required during therapy.

Safety & Side Effects

• Common: Diarrhea, stomach pain, loss of appetite, sore throat, nasal congestion, headache, nausea, vomiting, genital fungal infections, and increased urination.

• Occasional/serious: Low blood sugar (with other antidiabetics), dehydration, lactic acidosis (rare but serious—seek urgent care for severe weakness, breathing issues), urinary tract infection.

• Contact a doctor if unusual weakness, breathing trouble, severe abdominal pain, or signs of infection develop.

Note:
DAPZIGARD 5 M FORTE is best used as part of a comprehensive diabetes plan including healthy diet, regular exercise, and physician monitoring for best results and safety.

DAPZIGARD-10 M FORTE Tablet is an oral antidiabetic combination for adults with type 2 diabetes, used when single agents or lower-dose combinations do not achieve adequate glycemic control.

Uses / Indications

• Type 2 diabetes mellitus: Improves blood sugar control in adults, and is often prescribed alongside diet and exercise, or in combination with other antidiabetic agents.

• Complication prevention: Helps lower the risk of diabetic complications like kidney damage, retinopathy, heart attack, and amputation related to uncontrolled blood sugar.

How it Works / Key Benefits

• Dapagliflozin: Inhibits SGLT2 in the kidney, promoting glucose removal via urine; reduces both fasting and postprandial sugar, lowers blood pressure, and may aid weight loss.

• Metformin (ER): Reduces liver glucose output and improves insulin sensitivity throughout the body; extended release formulation provides stable, all-day glucose control with less GI irritation.

• Combination is more effective at controlling sugar than either agent alone, and also offers some protection against cardiovascular and renal complications.

Dosage & Administration

• One tablet daily (or as prescribed), with food; swallow whole, do not chew, crush, or split.

• Not for use in patients with type 1 diabetes, ketoacidosis, significant kidney/liver disease, or during pregnancy/breastfeeding.

• Maintain hydration, regular meal schedule, and continue blood sugar/kidney function monitoring as advised by your doctor.

Safety & Side Effects

• Common: Nausea, vomiting, diarrhea, urinary/genital fungal infection, sore throat, runny nose, headache, polyuria, flatulence, taste changes, mild low blood sugar (with other antidiabetics), dizziness.

• Occasional/serious: Lactic acidosis (with metformin—seek urgent medical attention if rapid breathing, fatigue, severe stomach pain), dehydration, urinary tract infection, allergic reaction.

• Avoid alcohol to lessen the risk of lactic acidosis and hypoglycemia.

• Good genital hygiene reduces risk of fungal infection; hydration helps prevent dehydration and kidney strain.

Note:
DAPZIGARD-10 M FORTE provides strong dual-agent control of blood sugar and diabetes complications, but must be used under medical supervision with attention to diet, exercise, hydration, and regular health monitoring for safety and effectiveness.

DAPZIGARD-10 T Tablet is a fixed-dose oral antidiabetic for adults with type 2 diabetes, used when previous regimens don’t provide adequate glycemic control or to simplify multidrug therapy.

Uses / Indications

• Type 2 diabetes mellitus: Lowers blood sugar in adults, especially those inadequately controlled by single or dual therapy, and is taken alongside a healthy diet and regular exercise.

• Can be used in combination with other oral antidiabetic agents as prescribed.

How it Works / Key Benefits

• Dapagliflozin: SGLT2 inhibitor—promotes urinary glucose excretion, lowers fasting and postprandial sugar, offers modest blood pressure/weight benefit and heart/kidney protection.

• Teneligliptin: DPP-4 inhibitor—increases insulin secretion and suppresses glucagon, blunting sugar rise after food and reducing HbA1c.

• Dual mechanism targets multiple pathways: SGLT2 inhibition for renal glucose excretion and DPP-4 inhibition for beta cell enhancement, giving pronounced glycemic lowering without significant weight gain or hypoglycemia risk (when used without sulfonylureas/insulin).

• Recent studies and real-world experience in India show effective and well-tolerated glycemic lowering with this combination.

Dosage & Administration

• Usually one tablet once daily at the same time each day, with or without food.

• Swallow whole with water—do not crush or chew.

• Not for type 1 diabetes, diabetic ketoacidosis, or in severe kidney/liver dysfunction.

• Regular blood sugar self-monitoring is essential, especially if combined with other antidiabetics.

Safety & Side Effects

• Common: Urinary/genital infection (itching/discomfort), increased urination, headache, diarrhea, nausea, upset stomach, dehydration.

• Serious (rare): DK (ketoacidosis with/without normal sugar), severe infection/allergy, pancreatitis, extreme weakness—seek urgent care for breathing difficulty, severe dehydration or unexplained pain.

• Hydration is crucial; inform the doctor if you have frequent infections or develop new symptoms.

Note:
DAPZIGARD-10 T is part of a modern diabetes care plan—maximize effect and safety with lifestyle management, periodic checkups, and by promptly reporting new symptoms to the treating physician.